Ollin Biosciences has announced positive topline results from its randomized, head-to-head Phase 1b JADE clinical study ...
“The non-invasive in vivo optical imaging of rhodopsin activation extends the diagnostic capability of ORG and may facilitate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback